On this tour, we explain how to use CRISPR/Cas systems for diagnostics and therapy of genetic diseases. In our lab, we are working toward developing CRISPR-based test assays to detect genetic mutations. These mutations have a range of effects that include an increased risk for different kidney diseases as well as changing how individuals metabolize drugs. We are also working with base editors, which are CRISPR/Cas-derived genome editing tools, to develop therapies for kidney diseases. Registration: central info point at the ground floor
Max-Delbrück-Centrum für Molekulare Medizin (MDC)
Seit 30 Jahren gibt es das Max-Delbrück-Centrum in Berlin, es ist ein weltweit führendes biomedizinisches Forschungszentrum. Wir analysieren das System Mensch – die Grundlagen des Lebens von seinen kleinsten Bausteinen bis zu organübergreifenden Mechanismen. So wollen wir Krankheiten vorbeugen, sie möglichst früh erkennen und passgenau therapieren.